http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI1101932-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95f291a3d926e2c44e6316a328d72324
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02C7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02C7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 2011-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa26a59cba7dd5bf5c587920516a4fa7
publicationDate 2014-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI1101932-A2
titleOfInvention MINIMIZING LIGHT EFFECT CONTACT LENS IN THE EYE LEMBIC REGION DURING CROSS LINK TREATMENT
abstract MINIMIZING CONTACT LENS OF THE EFFECT OF ULTRAVIOLET LIGHT IN THE EYE LIBRIC REGION DURING CROSS LINK TREATMENT. Utility Model Patent for peripheral protection of the cornea and limbic region, in whole or in part, through special contact lens, for cross link treatment
priorityDate 2011-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7048776
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426131764

Total number of triples: 15.